<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070524/" ref="ordinalpos=2711&amp;ncbi_uid=6289863&amp;link_uid=PMC4070524" image-link="/pmc/articles/PMC4070524/figure/F1/" class="imagepopup">Figure 1. MOR <span class="highlight" style="background-color:">signaling</span> networks and the MAPK <span class="highlight" style="background-color:">pathway</span> are dysregulated in human heroin abusers.  From: ELK1 transcription factor linked to dysregulated striatal mu opioid receptor <span class="highlight" style="background-color:">signaling</span> network and OPRM1 polymorphism in human heroin abusers. </a></div><br /><div class="p4l_captionBody">(A,B) Protein levels of MOR, β-arrestin2, MEK1, ERK1, ERK2, ELK1, and pELK1 in the putamen of human control subjects and heroin abusers. N=15 control, N=32 heroin. Representative bands are shown next to the histograms; Mean ± SEM. * p &lt; 0.05, ** p &lt; 0.01. (C) Schematic depiction of the MOR signaling networks. (D) Ratio of phosphorylated versus total ELK1 protein in human subjects. Abbreviations: C, CTL, control; H, HER, heroin.</div></div>